Quick answer
EHL BIO utilizes patented technology to extract Stromal Vascular Fraction (SVF) and culture Autologous Adipose-derived Stem Cells, ensuring high safety and reduced immune rejection. The process is conducted in Class 100 laboratories under GMP standards to achieve superior cell quality and viability.
Key takeaways
- Utilizes EHL BIO’s patented SVF extraction kit and technology.
- Achieves cell yield up to 1,000 times higher than typical competitors.
- Cells are processed and cultured in Class 100 clean rooms under GMP standards.
- Employs autologous cells to maximize safety and minimize side effects.
Why Choose Adipose-Derived Stem Cells?
Adipose-derived Stem Cells are a superior source of adult stem cells that can be easily collected and isolated in large quantities compared to other sources like bone marrow. These cells possess remarkable self-renewal capabilities and multipotentiality, allowing them to differentiate into various tissue types, including cartilage, muscle, and skin.
At EHL BIO, we primarily utilize autologous cells, which significantly reduces the risk of immune rejection, ensuring high safety for regenerative purposes. Furthermore, adipose-derived cells exhibit stable growth rates and excellent Homing Effects, enabling them to travel through the vascular system to accurately identify and repair damaged tissues within the body effectively.
Patented SVF Extraction and Innovative Technology
The heart of EHL BIO's technology lies in our patented Stromal Vascular Fraction (SVF) extraction kit, developed through over 5,000 liposuction procedures. This technology allows for the precise and safe isolation of high-purity stem cells from adipose tissue.
This extraction process is a cornerstone of our regenerative medicine development, including the production of ADSTEM for atopic dermatitis and research into neovascularization for myocardial infarction. The cells obtained through our patented equipment exhibit superior density and viability compared to conventional standards, significantly enhancing the potential for improved quality of life for our clients.
EHL BIO's cell isolation and cultivation technology delivers 1,000 times higher yield with Class 100 standards for maximum safety.
GMP Standards and Class 100 Facilities
EHL BIO prioritizes safety and cell quality above all else. We operate GMP-certified facilities, including GMP Center 1 and Center 2. EHL Cell Clinic features Class 100 facilities, representing the highest cleanliness standards in biopharmaceutical production.
Our research centers are equipped with advanced technology, such as Biological Safety Cabinets (BSC), AHU systems with HEPA filters, and liquid nitrogen storage systems at -196°C to preserve original cell characteristics. With a production capacity of up to 6,000 lots per year, we demonstrate global readiness and standards recognized by health ministries in Korea.

Service Procedures and Expert Research Team
EHL BIO's success is driven by a research team of over 85 experts, led by CEO MD Hong-gi Lee, focusing on integrating medical technology with pharmaceuticals. For clients in Thailand, EHL Thailand provides a dedicated Thai-speaking coordination team to assist at every step.
The process begins with a consultation and medical document evaluation, followed by travel planning to the EHL Cell Clinic in Apgujeong, Korea. A single adipose sample collection can be cultured and utilized for multiple treatments according to a personalized plan. Following strict quality-controlled cultivation, patients receive treatment and benefit from continuous follow-up upon returning to Thailand, ensuring the goal of rehabilitation and an enhanced quality of life.
Frequently asked questions
Is adipose cell isolation safe?
It is highly safe because EHL BIO uses the patient's own (autologous) adipose cells and operates in Class 100 GMP-certified laboratories, minimizing risks of contamination and immune rejection.
Why must cells be cultured in Korea?
Because EHL BIO has its research center and specific patented technology in Korea that can culture cells to a volume 1,000 times higher than usual, with international GMP certification.
What are the rehabilitation goals for the extracted cells?
They can be used in various regenerative medicine applications, such as osteoarthritis, atopic dermatitis, neurological conditions, and age-related degeneration, based on EHL team evaluation for better quality of life.
Related conditions
Based on EHL BIO information: EHL BIO · EHL BIO · EHL BIO · EHL BIO. Each care plan follows an individual EHL assessment.









